Global Insights Into Antipsychotic Research: Bridging Trends and Gaps in Schizophrenia Care (2000-2024).

IF 2.8 3区 医学 Q2 PHARMACOLOGY & PHARMACY
Lina M Gonzalez-Ojeda, Hernando Santamaría-García, Lina M Villegas, Catalina Trujillo-Llano, Juan F Cardona
{"title":"Global Insights Into Antipsychotic Research: Bridging Trends and Gaps in Schizophrenia Care (2000-2024).","authors":"Lina M Gonzalez-Ojeda, Hernando Santamaría-García, Lina M Villegas, Catalina Trujillo-Llano, Juan F Cardona","doi":"10.1097/JCP.0000000000002062","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Antipsychotic medications are pivotal in managing schizophrenia (SCZ), offering substantial relief from symptoms. However, their impact on functional outcomes, cognitive performance, social cognition, and quality of life remains a critical area of investigation. This bibliometric analysis examines research trends and insights into the multifaceted effects of antipsychotics on individuals with SCZ over the past 2 decades.</p><p><strong>Methods: </strong>Publications from the Scopus database (2000-2024) were analyzed using VOSviewer (V1.6.18) to conduct keyword co-occurrence, co-authorship, and bibliographic mapping analyses. Key trends and thematic areas were identified through bibliometric metrics.</p><p><strong>Results: </strong>The analysis included 2991 publications, revealing variability in annual publication rates. Schizophrenia Research was the leading journal, while the United States dominated in publication volume, author contributions, and institutional output. Key thematic areas included atypical antipsychotics, cognitive impacts, neurotransmitter mechanisms, treatment modalities, quality of life, cognitive deficits, negative symptoms, and neuroimaging studies. Despite advancements, significant gaps persist in understanding social cognition and the holistic impact of antipsychotics.</p><p><strong>Conclusions: </strong>This bibliometric analysis highlights the complex landscape of antipsychotic research in SCZ, underscoring progress in understanding executive functions, motor side effects, and metabolic impacts. However, the findings reveal a critical need for research into social cognition and culturally diverse populations. Addressing these gaps is essential for developing integrated treatment strategies that combine pharmacological, psychosocial, and family-based interventions. Expanding research to encompass diverse ethnic, cultural, and socioeconomic contexts is imperative for advancing global psychiatric care and ensuring equitable treatment access.</p>","PeriodicalId":15455,"journal":{"name":"Journal of Clinical Psychopharmacology","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/JCP.0000000000002062","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Antipsychotic medications are pivotal in managing schizophrenia (SCZ), offering substantial relief from symptoms. However, their impact on functional outcomes, cognitive performance, social cognition, and quality of life remains a critical area of investigation. This bibliometric analysis examines research trends and insights into the multifaceted effects of antipsychotics on individuals with SCZ over the past 2 decades.

Methods: Publications from the Scopus database (2000-2024) were analyzed using VOSviewer (V1.6.18) to conduct keyword co-occurrence, co-authorship, and bibliographic mapping analyses. Key trends and thematic areas were identified through bibliometric metrics.

Results: The analysis included 2991 publications, revealing variability in annual publication rates. Schizophrenia Research was the leading journal, while the United States dominated in publication volume, author contributions, and institutional output. Key thematic areas included atypical antipsychotics, cognitive impacts, neurotransmitter mechanisms, treatment modalities, quality of life, cognitive deficits, negative symptoms, and neuroimaging studies. Despite advancements, significant gaps persist in understanding social cognition and the holistic impact of antipsychotics.

Conclusions: This bibliometric analysis highlights the complex landscape of antipsychotic research in SCZ, underscoring progress in understanding executive functions, motor side effects, and metabolic impacts. However, the findings reveal a critical need for research into social cognition and culturally diverse populations. Addressing these gaps is essential for developing integrated treatment strategies that combine pharmacological, psychosocial, and family-based interventions. Expanding research to encompass diverse ethnic, cultural, and socioeconomic contexts is imperative for advancing global psychiatric care and ensuring equitable treatment access.

抗精神病药物研究的全球洞察:弥合精神分裂症治疗的趋势和差距(2000-2024)。
背景:抗精神病药物是治疗精神分裂症(SCZ)的关键,提供实质性的缓解症状。然而,它们对功能结果、认知表现、社会认知和生活质量的影响仍然是一个关键的研究领域。本文献计量学分析考察了过去20年来抗精神病药物对SCZ患者多方面影响的研究趋势和见解。方法:采用VOSviewer (V1.6.18)软件对Scopus数据库2000-2024年的出版物进行关键词共现、合著、书目配图分析。通过文献计量方法确定了主要趋势和专题领域。结果:该分析包括2991篇出版物,揭示了年发表率的变异性。精神分裂症研究是领先的期刊,而美国在出版物数量,作者贡献和机构产出方面占主导地位。主要专题领域包括非典型抗精神病药物、认知影响、神经递质机制、治疗方式、生活质量、认知缺陷、阴性症状和神经影像学研究。尽管取得了进步,但在理解社会认知和抗精神病药物的整体影响方面仍然存在重大差距。结论:这一文献计量学分析强调了SCZ抗精神病药物研究的复杂性,强调了在理解执行功能、运动副作用和代谢影响方面的进展。然而,研究结果表明,迫切需要对社会认知和文化多样性人群进行研究。解决这些差距对于制定结合药物、社会心理和家庭干预措施的综合治疗战略至关重要。扩大研究范围,以涵盖不同的种族、文化和社会经济背景,对于推进全球精神病学护理和确保公平获得治疗至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.00
自引率
3.40%
发文量
231
审稿时长
4-8 weeks
期刊介绍: Journal of Clinical Psychopharmacology, a leading publication in psychopharmacology, offers a wide range of articles reporting on clinical trials and studies, side effects, drug interactions, overdose management, pharmacogenetics, pharmacokinetics, and psychiatric effects of non-psychiatric drugs. The journal keeps clinician-scientists and trainees up-to-date on the latest clinical developments in psychopharmacologic agents, presenting the extensive coverage needed to keep up with every development in this fast-growing field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信